Anticoagulants, Antibiotics, and Anticancer Drugs Development
Location: South Korea
Investors 3
| Date | Name | Website |
| - | Korea Inve... | partners.k... |
| - | Krypton | krypton36.... |
| - | Yuanta Inv... | yuantainve... |
Mentions in press and media 2
| Date | Title | Description |
| 14.02.2023 | South Korean Biotech acquires first-in-class antibody from Elthera | |
| 10.06.2021 | WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates | WUXI, China and DAEJEON, South Korea, June 10, 2021 /PRNewswire/ -- WuXi XDC ("XDC"), a global CDMO company dedicated to end-to-end bioconjugates services, and LegoChem Biosciences (141080KS, "LCB"), today announced that... |